$CHPT
ChargePoint Holdings, Inc. Stock $chpt

$chpt Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000177739323000008 Filed on April 03, 2023

Income Statement

Concept	2023 Q1	2023	2022
Revenue	$152.8M	$468.1M	$241.0M
YoY Change	92.62%	94.23%	64.52%
Cost Of Revenue	$119.8M	$382.2M	$187.5M
YoY Change	93.73%	103.85%	65.11%
Gross Profit	$32.99M	$85.93M	$53.53M
YoY Change	88.71%	60.52%	62.47%
Gross Profit Margin	21.59%	18.36%	22.21%
Selling, General & Admin	$64.58M	$232.8M	$173.9M
YoY Change	19.58%	33.82%	120.38%
% of Gross Profit	195.74%	270.86%	324.9%
Research & Development	$46.72M	$195.0M	$145.0M
YoY Change	9.91%	34.41%	93.35%
% of Gross Profit	141.61%	226.87%	270.94%
Depreciation & Amortization	$6.488M	$25.05M	$16.46M
YoY Change	3.0%	52.21%	63.22%
% of Gross Profit	19.67%	29.15%	30.74%
Operating Expenses	$111.3M	$427.7M	$319.0M
YoY Change	15.32%	34.09%	107.2%
Operating Profit	-$78.31M	-$341.8M	-$265.4M
YoY Change	-0.92%	28.76%	119.39%
Interest Expense	-$903.0K	-$3.900M	$1.502M
YoY Change	-3573.08%	-359.65%	-53.83%
% of Operating Profit
Other Income/Expense, Net	$1.078M	-$1.593M	-$2.775M
YoY Change	-93.4%	-42.59%	-1311.79%
Pretax Income	-$78.13M	-$347.3M	-$135.2M
YoY Change	24.28%	156.92%	-31.32%
Income Tax	-$119.0K	-$2.816M	-$2.930M
% Of Pretax Income
Net Earnings	-$78.01M	-$344.5M	-$132.2M
YoY Change	29.7%	160.48%	-32.88%
Net Earnings / Revenue	-51.05%	-73.59%	-54.87%
Basic Earnings Per Share		-$1.02	-$1.01
Diluted Earnings Per Share	-$0.23	-$1.02	-$1.49
COMMON SHARES
Basic Shares Outstanding	350.5M shares	338.5M shares	297.4M shares
Diluted Shares Outstanding		338.5M shares	302.5M shares

Balance Sheet

Concept	2023 Q1	2023	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$369.1M	$369.1M	$315.2M
YoY Change	17.1%	17.1%	116.67%
Cash & Equivalents	$264.2M	$264.2M	$315.2M
Short-Term Investments	$105.0M	$105.0M
Other Short-Term Assets	$101.4M	$101.4M	$37.00M
YoY Change	416.08%	174.09%	196.64%
Inventory	$68.73M	$68.73M	$35.88M
Prepaid Expenses	$48.46M
Receivables	$164.9M	$164.9M	$75.94M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$704.2M	$704.2M	$464.1M
YoY Change	51.74%	51.74%	104.76%
LONG-TERM ASSETS
Property, Plant & Equipment	$62.29M	$62.29M	$60.13M
YoY Change	80.06%	3.59%	16.07%
Goodwill	$213.7M
YoY Change	-2.18%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$7.110M	$7.110M	$6.020M
YoY Change	18.11%	18.11%	-42.49%
Total Long-Term Assets	$375.8M	$375.8M	$391.8M
YoY Change	-4.1%	-4.1%	517.19%
TOTAL ASSETS
Total Short-Term Assets	$704.2M	$704.2M	$464.1M
Total Long-Term Assets	$375.8M	$375.8M	$391.8M
Total Assets	$1.080B	$1.080B	$855.9M
YoY Change	26.18%	26.18%	195.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$62.08M	$62.08M	$27.58M
YoY Change	125.11%	125.11%	39.39%
Accrued Expenses	$133.3M	$133.3M	$61.28M
YoY Change	318.46%	117.59%	62.01%
Deferred Revenue	$88.78M
YoY Change	15.08%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due			$0.00
YoY Change			-100.0%
Total Short-Term Liabilities	$284.2M	$284.2M	$189.0M
YoY Change	50.33%	50.33%	60.09%
LONG-TERM LIABILITIES
Long-Term Debt	$294.9M	$294.9M	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$132.7M	$132.7M	$102.1M
YoY Change	1768.05%	29.93%	-31.07%
Total Long-Term Liabilities	$427.6M	$427.6M	$102.1M
YoY Change	5919.74%	318.68%	-40.91%
TOTAL LIABILITIES
Total Short-Term Liabilities	$284.2M	$284.2M	$189.0M
Total Long-Term Liabilities	$427.6M	$427.6M	$102.1M
Total Liabilities	$724.3M	$724.3M	$308.9M
YoY Change	134.5%	134.5%	6.17%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.157B
YoY Change	42.52%
Common Stock	$35.00K
YoY Change	6.06%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$355.6M	$355.6M	$547.0M
YoY Change
Total Liabilities & Shareholders Equity	$1.080B	$1.080B	$855.9M
YoY Change	26.18%	26.18%	195.01%

Cashflow Statement

Concept	2023 Q1	2023	2022
OPERATING ACTIVITIES
Net Income	-$78.01M	-$344.5M	-$132.2M
YoY Change	29.7%	160.48%	-32.88%
Depreciation, Depletion And Amortization	$6.488M	$25.05M	$16.46M
YoY Change	3.0%	52.21%	63.22%
Cash From Operating Activities	-$50.40M	-$267.0M	-$157.2M
YoY Change	4.79%	69.9%	71.13%
INVESTING ACTIVITIES
Capital Expenditures	$4.421M	$18.56M	$16.41M
YoY Change	-201.73%	13.12%	42.89%
Acquisitions		$2.756M	$205.3M
YoY Change		-98.66%
Other Investing Activities	$105.0M	-$107.6M	-$205.3M
YoY Change	-10500100.0%	-47.6%	-536.74%
Cash From Investing Activities	$100.6M	-$126.2M	-$221.7M
YoY Change	-2413.76%	-43.11%	-724.09%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$50.67M	$67.78M
YoY Change
Debt Paid & Issued, Net		$0.00	$36.05M
YoY Change		-100.0%
Cash From Financing Activities	54.86M	372.9M	$549.7M
YoY Change	2127.45%	-32.17%	326.4%
NET CHANGE
Cash From Operating Activities	-50.40M	-267.0M	-$157.2M
Cash From Investing Activities	100.6M	-126.2M	-$221.7M
Cash From Financing Activities	54.86M	372.9M	$549.7M
Net Change In Cash	105.0M	-20.34M	$169.7M
YoY Change	-310.17%	-111.99%	133.36%
FREE CASH FLOW
Cash From Operating Activities	-$50.40M	-$267.0M	-$157.2M
Capital Expenditures	$4.421M	$18.56M	$16.41M
Free Cash Flow	-$54.82M	-$285.6M	-$173.6M
YoY Change	25.3%	64.53%	67.99%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001777393
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-84420000	usd
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2023	chpt	Payments Of Reverse Recapitalization Transaction Costs PaymentsOfReverseRecapitalizationTransactionCosts	0	usd
CY2022	chpt	Payments Of Reverse Recapitalization Transaction Costs PaymentsOfReverseRecapitalizationTransactionCosts	-7031000	usd
CY2021	chpt	Payments Of Reverse Recapitalization Transaction Costs PaymentsOfReverseRecapitalizationTransactionCosts	0	usd
CY2023Q1	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://chargepoint.com/20230131#AccruedLiabilitiesAndOtherLiabilitiesCurrent
CY2022Q1	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://chargepoint.com/20230131#AccruedLiabilitiesAndOtherLiabilitiesCurrent
CY2023Q1	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss Statement Of Financial Position Extensible List DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#AvailableForSaleSecuritiesDebtSecuritiesCurrent
CY2022Q1	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss Statement Of Financial Position Extensible List DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#AvailableForSaleSecuritiesDebtSecuritiesCurrent
CY2021	us-gaap	Fair Value Net Derivative Asset Liability Recurring Basis Still Held Unrealized Gain Loss Statement Of Income Extensible List FairValueNetDerivativeAssetLiabilityRecurringBasisStillHeldUnrealizedGainLossStatementOfIncomeExtensibleList	http://fasb.org/us-gaap/2022#FairValueAdjustmentOfWarrants
CY2022	us-gaap	Fair Value Net Derivative Asset Liability Recurring Basis Still Held Unrealized Gain Loss Statement Of Income Extensible List FairValueNetDerivativeAssetLiabilityRecurringBasisStillHeldUnrealizedGainLossStatementOfIncomeExtensibleList	http://fasb.org/us-gaap/2022#FairValueAdjustmentOfWarrants
CY2023	us-gaap	Fair Value Net Derivative Asset Liability Recurring Basis Still Held Unrealized Gain Loss Statement Of Income Extensible List FairValueNetDerivativeAssetLiabilityRecurringBasisStillHeldUnrealizedGainLossStatementOfIncomeExtensibleList	http://fasb.org/us-gaap/2022#FairValueAdjustmentOfWarrants
CY2023	chpt	Number Of Days Determining Earnout Triggering Event NumberOfDaysDeterminingEarnoutTriggeringEvent	P10Y
CY2022Q1	us-gaap	Derivative Liability Statement Of Financial Position Extensible Enumeration DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2023Q1	us-gaap	Derivative Liability Statement Of Financial Position Extensible Enumeration DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2022	us-gaap	Derivative Gain Statement Of Income Or Comprehensive Income Extensible Enumeration DerivativeGainStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2022#FairValueAdjustmentOfWarrants
CY2021	us-gaap	Derivative Gain Statement Of Income Or Comprehensive Income Extensible Enumeration DerivativeGainStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2022#FairValueAdjustmentOfWarrants
CY2023	us-gaap	Derivative Gain Statement Of Income Or Comprehensive Income Extensible Enumeration DerivativeGainStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2022#FairValueAdjustmentOfWarrants
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--01-31
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Public Float EntityPublicFloat	4100000000	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	350493445	shares
CY2023	dei	Auditor Firm AuditorFirmId	238
CY2023	dei	Auditor Name AuditorName	PricewaterhouseCoopers LLP
CY2023	dei	Auditor Location AuditorLocation	San Jose, California
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	264162000	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	315235000	usd
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	30400000	usd
CY2022Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	400000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	104966000	usd
CY2022Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	0	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	10000000	usd
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	5584000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	164892000	usd
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	75939000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	68730000	usd
CY2022Q1	us-gaap	Inventory Net InventoryNet	35879000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	71020000	usd
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	36603000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	704170000	usd
CY2022Q1	us-gaap	Assets Current AssetsCurrent	464056000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	40046000	usd
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	34593000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	92673000	usd
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	107209000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	22242000	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	25535000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	213716000	usd
CY2022Q1	us-gaap	Goodwill Goodwill	218484000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	7110000	usd
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6020000	usd
CY2023Q1	us-gaap	Assets Assets	1079957000	usd
CY2022Q1	us-gaap	Assets Assets	855897000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	62076000	usd
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	27576000	usd
CY2023Q1	chpt	Accrued Liabilities And Other Liabilities Current AccruedLiabilitiesAndOtherLiabilitiesCurrent	133483000	usd
CY2022Q1	chpt	Accrued Liabilities And Other Liabilities Current AccruedLiabilitiesAndOtherLiabilitiesCurrent	84328000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	88777000	usd
CY2022Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	77142000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	284336000	usd
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	189046000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	109833000	usd
CY2022Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	69666000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	294936000	usd
CY2022Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	21841000	usd
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	25370000	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	12987000	usd
CY2022Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	17697000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1032000	usd
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	7104000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	724965000	usd
CY2022Q1	us-gaap	Liabilities Liabilities	308883000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	348330481	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	348330481	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	334760615	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	334760615	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	35000	usd
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	33000	usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1528104000	usd
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1366855000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-16384000	usd
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-8219000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1156763000	usd
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-811655000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	354992000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	547014000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1079957000	usd
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	855897000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	468094000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	241006000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	146490000	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	382161000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	187473000	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	113541000	usd
CY2023	us-gaap	Gross Profit GrossProfit	85933000	usd
CY2022	us-gaap	Gross Profit GrossProfit	53533000	usd
CY2021	us-gaap	Gross Profit GrossProfit	32949000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	194957000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	145043000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	75017000	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	142392000	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	92550000	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	53002000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	90366000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	81380000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	25922000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	427715000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	338488667	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	297421969	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15116763	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	338488667	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	302490266	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15116763	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.02
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.01
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-18.14
CY2022	us-gaap	Operating Expenses OperatingExpenses	318973000	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	153941000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-341782000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-265440000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-120992000	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	98000	usd
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	315000	usd
CY2021	us-gaap	Interest Expense InterestExpense	3253000	usd
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-84420000	usd
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2023	chpt	Payments Of Reverse Recapitalization Transaction Costs PaymentsOfReverseRecapitalizationTransactionCosts	0	usd
CY2022	chpt	Payments Of Reverse Recapitalization Transaction Costs PaymentsOfReverseRecapitalizationTransactionCosts	-7031000	usd
CY2021	chpt	Payments Of Reverse Recapitalization Transaction Costs PaymentsOfReverseRecapitalizationTransactionCosts	0	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1569000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2775000	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	229000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-347275000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-135171000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-196826000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2167000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2930000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	198000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-345108000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-132241000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-197024000	usd
CY2023	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	0	usd
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	0	usd
CY2021	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	60377000	usd
CY2023	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	0	usd
CY2022	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	4292000	usd
CY2021	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	16799000	usd
CY2023	chpt	Deemed Dividends Attributable To Vested Option Holders DeemedDividendsAttributableToVestedOptionHolders	0	usd
CY2022	chpt	Deemed Dividends Attributable To Vested Option Holders DeemedDividendsAttributableToVestedOptionHolders	51855000	usd
CY2021	chpt	Deemed Dividends Attributable To Vested Option Holders DeemedDividendsAttributableToVestedOptionHolders	0	usd
CY2023	chpt	Deemed Dividends Attributable To Common Stock Warrant Holders DeemedDividendsAttributableToCommonStockWarrantHolders	0	usd
CY2022	chpt	Deemed Dividends Attributable To Common Stock Warrant Holders DeemedDividendsAttributableToCommonStockWarrantHolders	110635000	usd
CY2021	chpt	Deemed Dividends Attributable To Common Stock Warrant Holders DeemedDividendsAttributableToCommonStockWarrantHolders	0	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-345108000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-299023000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-274200000	usd
CY2023	chpt	Dilutive Securities Effect On Basic Earnings Per Share Dilutive Gain On Earnout Shares Issued DilutiveSecuritiesEffectOnBasicEarningsPerShareDilutiveGainOnEarnoutSharesIssued	0	usd
CY2022	chpt	Dilutive Securities Effect On Basic Earnings Per Share Dilutive Gain On Earnout Shares Issued DilutiveSecuritiesEffectOnBasicEarningsPerShareDilutiveGainOnEarnoutSharesIssued	84420000	usd
CY2021	chpt	Dilutive Securities Effect On Basic Earnings Per Share Dilutive Gain On Earnout Shares Issued DilutiveSecuritiesEffectOnBasicEarningsPerShareDilutiveGainOnEarnoutSharesIssued	0	usd
CY2023	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	0	usd
CY2022	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	-68223000	usd
CY2021	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	0	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-345108000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-451666000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-274200000	usd
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.02
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	93351000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-8165000	usd
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.49
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-18.14
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-345108000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-132241000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-197024000	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-7716000	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-8374000	usd
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	141000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax	-449000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax	0	usd
CY2021	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax	0	usd
CY2023	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	0	usd
CY2022	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	0	usd
CY2021	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-23000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-8165000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-8374000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	118000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-353273000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-140615000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-196906000	usd
CY2020Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	160583203	shares
CY2020Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	520241000	usd
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	-462021000	usd
CY2021	chpt	Temporary Equity Stock Issued During Period Shares New Issues TemporaryEquityStockIssuedDuringPeriodSharesNewIssues	22351054	shares
CY2021	us-gaap	Temporary Equity Stock Issued During Period Value New Issues TemporaryEquityStockIssuedDuringPeriodValueNewIssues	95456000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	31547000	usd
CY2021	chpt	Temporary Equity Beneficial Conversion Feature TemporaryEquityBeneficialConversionFeature	60377000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	60377000	usd
CY2021	chpt	Temporary Equity Accretion Of Beneficial Conversion Feature TemporaryEquityAccretionOfBeneficialConversionFeature	60377000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	60377000	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5644000	usd
CY2021	chpt	Adjustments To Additional Paid In Capital Early Exercised Options Vested AdjustmentsToAdditionalPaidInCapitalEarlyExercisedOptionsVested	268000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4947000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-197024000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	118000	usd
CY2021Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	182934257	shares
CY2021Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	615697000	usd
CY2022	chpt	Temporary Equity Issued During Period Shares Conversion Of Convertible Securities Including Paid In Kind Dividend TemporaryEquityIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesIncludingPaidInKindDividend	182934257	shares
CY2022	chpt	Temporary Equity Issued During Period Value Conversion Of Convertible Securities Including Paid In Kind Dividend TemporaryEquityIssuedDuringPeriodValueConversionOfConvertibleSecuritiesIncludingPaidInKindDividend	615697000	usd
CY2022	chpt	Stock Issued During Period Value Conversion Of Convertible Securities Including Paid In Kind Dividend StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesIncludingPaidInKindDividend	615697000	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	4516000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	66606000	usd
CY2022	chpt	Stock Issued During Period Value Reverse Recapitalization StockIssuedDuringPeriodValueReverseRecapitalization	200466000	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	352613000	usd
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	102058000	usd
CY2022	chpt	Stock Issued During Period Value Earnout Shares StockIssuedDuringPeriodValueEarnoutShares	480225000	usd
CY2022	chpt	Adjustments To Additional Paid In Capital Reverse Recapitalization Contingent Earnout Liability Recognized AdjustmentsToAdditionalPaidInCapitalReverseRecapitalizationContingentEarnoutLiabilityRecognized	-828180000	usd
CY2022	chpt	Adjustments To Additional Paid In Capital Reclassification Of Contingent Earnout Liability AdjustmentsToAdditionalPaidInCapitalReclassificationOfContingentEarnoutLiability	242640000	usd
CY2022	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	1588	shares
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	67331000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-132241000	usd
CY2023Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-8374000	usd
CY2022Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2022Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	547014000	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2502000	usd
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	6932000	usd
CY2023	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	8947000	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	49450000	usd
CY2023	chpt	Adjustments To Additional Paid In Capital Early Exercised Options Vested AdjustmentsToAdditionalPaidInCapitalEarlyExercisedOptionsVested	69000	usd
CY2023	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	4664	shares
CY2023	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	284835000	usd
CY2022	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	0	usd
CY2021	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	0	usd
CY2023	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	180000000	usd
CY2022	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	0	usd
CY2023Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	354992000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-345108000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-132241000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-197024000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	25050000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	16457000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	10083000	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	4739000	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	4244000	usd
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	3762000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	93350000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	67331000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	4947000	usd
CY2023	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	2361000	usd
CY2022	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	1786000	usd
CY2021	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	1206000	usd
CY2023	chpt	Transaction Costs Expensed TransactionCostsExpensed	0	usd
CY2022	chpt	Transaction Costs Expensed TransactionCostsExpensed	7031000	usd
CY2021	chpt	Transaction Costs Expensed TransactionCostsExpensed	0	usd
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-84420000	usd
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2023	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-16832000	usd
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-374000	usd
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1858000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	94600000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	38388000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3292000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	39358000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1991000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	9585000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	37969000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	23941000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	8914000	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-5043000	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-3460000	usd
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-2815000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	31476000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	7933000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-493000	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	29394000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	21619000	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	11556000	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	51803000	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	55281000	usd
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	17156000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-267049000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-157178000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-91846000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	18563000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	16410000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	11484000	usd
CY2021	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	47014000	usd
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	2756000	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	205330000	usd
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-126154000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-221740000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	35530000	usd
CY2023	us-gaap	Proceeds From Issuance Of Redeemable Convertible Preferred Stock ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Redeemable Convertible Preferred Stock ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Redeemable Convertible Preferred Stock ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock	95456000	usd
CY2023	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	6884000	usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	118864000	usd
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
CY2023	chpt	Proceeds From Reverse Recapitalization Transaction ProceedsFromReverseRecapitalizationTransaction	0	usd
CY2022	chpt	Proceeds From Reverse Recapitalization Transaction ProceedsFromReverseRecapitalizationTransaction	511646000	usd
CY2021	chpt	Proceeds From Reverse Recapitalization Transaction ProceedsFromReverseRecapitalizationTransaction	0	usd
CY2023	chpt	Payments Tax Withholding Reverse Recapitalization Earnout Shares PaymentsTaxWithholdingReverseRecapitalizationEarnoutShares	0	usd
CY2022	chpt	Payments Tax Withholding Reverse Recapitalization Earnout Shares PaymentsTaxWithholdingReverseRecapitalizationEarnoutShares	20895000	usd
CY2021	chpt	Payments Tax Withholding Reverse Recapitalization Earnout Shares PaymentsTaxWithholdingReverseRecapitalizationEarnoutShares	0	usd
CY2023	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	usd
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	36051000	usd
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	usd
CY2023	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	31547000	usd
CY2023	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	293972000	usd
CY2022	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	0	usd
CY2023	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	0	usd
CY2022	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	32468000	usd
CY2021	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	0	usd
CY2023	chpt	Proceeds For Payments Of Driver Funds And Amounts Due To Customers ProceedsForPaymentsOfDriverFundsAndAmountsDueToCustomers	11107000	usd
CY2022	chpt	Proceeds For Payments Of Driver Funds And Amounts Due To Customers ProceedsForPaymentsOfDriverFundsAndAmountsDueToCustomers	3675000	usd
CY2021	chpt	Proceeds For Payments Of Driver Funds And Amounts Due To Customers ProceedsForPaymentsOfDriverFundsAndAmountsDueToCustomers	0	usd
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	4003000	usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	11446000	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	4916000	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5913000	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	49450000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	372859000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	549687000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	128913000	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-729000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1025000	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	141000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-21073000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	169744000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	72738000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	315635000	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	145891000	usd
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	73153000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	294562000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	315635000	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	145891000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	4929000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	346000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	2801000	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	598000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	268000	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	172000	usd
CY2023	chpt	Accretion Of Beneficial Conversion Feature Of Redeemable Convertible Preferred Stock AccretionOfBeneficialConversionFeatureOfRedeemableConvertiblePreferredStock	0	usd
CY2022	chpt	Accretion Of Beneficial Conversion Feature Of Redeemable Convertible Preferred Stock AccretionOfBeneficialConversionFeatureOfRedeemableConvertiblePreferredStock	0	usd
CY2021	chpt	Accretion Of Beneficial Conversion Feature Of Redeemable Convertible Preferred Stock AccretionOfBeneficialConversionFeatureOfRedeemableConvertiblePreferredStock	60377000	usd
CY2023	chpt	Deferred Transaction Costs Incurred But Not Yet Paid DeferredTransactionCostsIncurredButNotYetPaid	0	usd
CY2022	chpt	Deferred Transaction Costs Incurred But Not Yet Paid DeferredTransactionCostsIncurredButNotYetPaid	0	usd
CY2021	chpt	Deferred Transaction Costs Incurred But Not Yet Paid DeferredTransactionCostsIncurredButNotYetPaid	1685000	usd
CY2023	chpt	Right Of Use Asset Obtained In Exchange For Operating And Finance Lease Liability RightOfUseAssetObtainedInExchangeForOperatingAndFinanceLeaseLiability	0	usd
CY2022	chpt	Right Of Use Asset Obtained In Exchange For Operating And Finance Lease Liability RightOfUseAssetObtainedInExchangeForOperatingAndFinanceLeaseLiability	7991000	usd
CY2021	chpt	Right Of Use Asset Obtained In Exchange For Operating And Finance Lease Liability RightOfUseAssetObtainedInExchangeForOperatingAndFinanceLeaseLiability	2118000	usd
CY2023	chpt	Right Of Use Asset Remeasurement RightOfUseAssetRemeasurement	0	usd
CY2022	chpt	Right Of Use Asset Remeasurement RightOfUseAssetRemeasurement	0	usd
CY2021	chpt	Right Of Use Asset Remeasurement RightOfUseAssetRemeasurement	12867000	usd
CY2023	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1954000	usd
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	660000	usd
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	647000	usd
CY2023	chpt	Vesting Of Early Exercised Stock Options VestingOfEarlyExercisedStockOptions	69000	usd
CY2022	chpt	Vesting Of Early Exercised Stock Options VestingOfEarlyExercisedStockOptions	178000	usd
CY2021	chpt	Vesting Of Early Exercised Stock Options VestingOfEarlyExercisedStockOptions	268000	usd
CY2023	chpt	Reverse Recapitalization Conversion Of Redeemable Convertible Preferred Stock Into Common Stock ReverseRecapitalizationConversionOfRedeemableConvertiblePreferredStockIntoCommonStock	0	usd
CY2022	chpt	Reverse Recapitalization Conversion Of Redeemable Convertible Preferred Stock Into Common Stock ReverseRecapitalizationConversionOfRedeemableConvertiblePreferredStockIntoCommonStock	615697000	usd
CY2021	chpt	Reverse Recapitalization Conversion Of Redeemable Convertible Preferred Stock Into Common Stock ReverseRecapitalizationConversionOfRedeemableConvertiblePreferredStockIntoCommonStock	0	usd
CY2023	chpt	Reverse Recapitalization Reclassification Of Redeemable Convertible Preferred Stock Warrant Liability ReverseRecapitalizationReclassificationOfRedeemableConvertiblePreferredStockWarrantLiability	0	usd
CY2022	chpt	Reverse Recapitalization Reclassification Of Redeemable Convertible Preferred Stock Warrant Liability ReverseRecapitalizationReclassificationOfRedeemableConvertiblePreferredStockWarrantLiability	66606000	usd
CY2021	chpt	Reverse Recapitalization Reclassification Of Redeemable Convertible Preferred Stock Warrant Liability ReverseRecapitalizationReclassificationOfRedeemableConvertiblePreferredStockWarrantLiability	0	usd
CY2023	chpt	Reverse Recapitalization Contingent Earnout Liability Recognized ReverseRecapitalizationContingentEarnoutLiabilityRecognized	0	usd
CY2022	chpt	Reverse Recapitalization Contingent Earnout Liability Recognized ReverseRecapitalizationContingentEarnoutLiabilityRecognized	828180000	usd
CY2021	chpt	Reverse Recapitalization Contingent Earnout Liability Recognized ReverseRecapitalizationContingentEarnoutLiabilityRecognized	0	usd
CY2023	chpt	Reclassification Of Remaining Contingent Earnout Liability Upon Triggering Event ReclassificationOfRemainingContingentEarnoutLiabilityUponTriggeringEvent	0	usd
CY2022	chpt	Reclassification Of Remaining Contingent Earnout Liability Upon Triggering Event ReclassificationOfRemainingContingentEarnoutLiabilityUponTriggeringEvent	242640000	usd
CY2021	chpt	Reclassification Of Remaining Contingent Earnout Liability Upon Triggering Event ReclassificationOfRemainingContingentEarnoutLiabilityUponTriggeringEvent	0	usd
CY2023	us-gaap	Stock Issued1 StockIssued1	0	usd
CY2022	us-gaap	Stock Issued1 StockIssued1	102057000	usd
CY2021	us-gaap	Stock Issued1 StockIssued1	0	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1156800000	usd
CY2021Q1	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	484100000	usd
CY2023Q1	chpt	Cash Cash Equivalents Restricted Cash Restricted Cash Equivalents And Short Term Investments CashCashEquivalentsRestrictedCashRestrictedCashEquivalentsAndShortTermInvestments	399500000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	The preparation of the accompanying consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of revenue and expenses. Actual results and outcomes could differ significantly from the Company’s estimates, judgments, and assumptions. Significant estimates include determining standalone selling price for performance obligations in contracts with customers, the estimated expected benefit period for deferred contract acquisition costs, allowances for expected credit losses, inventory reserves, the useful lives of long-lived assets, the determination of the incremental borrowing rate used for operating lease liabilities, valuation of acquired goodwill and intangible assets, the value of common stock and other assumptions used to measure stock-based compensation, and the valuation of deferred income tax assets and uncertain tax positions. These estimates and assumptions are based on management’s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future periods. As future events and their effects cannot be determined with precision, actual results could materially differ from those estimates and assumptions.
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to credit risk consist primarily of cash and cash equivalents, short-term investments, and accounts receivable. Cash and cash equivalents are held in domestic and foreign cash accounts across large, creditworthy financial institutions. The Company has not experienced any losses on its deposits of cash and cash equivalents through deposits with federally insured commercial banks and at times cash balances may be in excess of federal insurance limits. Short-term investments consist of U.S. treasury bills that carry high-credit ratings and accordingly, minimal credit risk exists with respect to these balances.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable are stated at the amount the Company expects to collect. The Company generally does not require collateral or other security in support of accounts receivable. To reduce credit risk, management performs ongoing credit evaluations of its customers’ financial condition.</span></div>
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	264162000	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	315235000	usd
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	145491000	usd
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	30400000	usd
CY2022Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	400000	usd
CY2021Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	400000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	294562000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	315635000	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	145891000	usd
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	5584000	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	6353000	usd
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	1937000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	10000000	usd
CY2023	chpt	Capitalized Contract Cost Additions CapitalizedContractCostAdditions	3374000	usd
CY2023	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	2361000	usd
CY2023Q1	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	8142000	usd
CY2023Q1	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	2598000	usd
CY2022Q1	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	2104000	usd
CY2023Q1	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	5544000	usd
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2023Q1	us-gaap	Goodwill Goodwill	213700000	usd
CY2022Q1	us-gaap	Goodwill Goodwill	218500000	usd
CY2022Q1	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	0	usd
CY2022Q1	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	5025000	usd
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	222400000	usd
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.43
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	198610000	usd
CY2022Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	146808000	usd
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	77142000	usd
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	40934000	usd
CY2021	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	39400000	usd
CY2023Q1	us-gaap	Capitalized Contract Cost Amortization Period CapitalizedContractCostAmortizationPeriod	P5Y
CY2021Q1	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	5534000	usd
CY2022	chpt	Capitalized Contract Cost Additions CapitalizedContractCostAdditions	3381000	usd
CY2022	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	1786000	usd
CY2022Q1	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	7129000	usd
CY2023Q1	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	8142000	usd
CY2022Q1	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	7129000	usd
CY2023	us-gaap	Advertising Expense AdvertisingExpense	0	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	0	usd
CY2021	us-gaap	Advertising Expense AdvertisingExpense	0	usd
CY2023	us-gaap	Product Warranty Expense ProductWarrantyExpense	5400000	usd
CY2022	us-gaap	Product Warranty Expense ProductWarrantyExpense	3800000	usd
CY2021	us-gaap	Product Warranty Expense ProductWarrantyExpense	3400000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	33146000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	92673000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss	500000	usd
CY2021Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	0	usd
CY2022Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	0	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	0	usd
CY2021Q1	us-gaap	Goodwill Goodwill	1215000	usd
CY2022	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-4567000	usd
CY2022Q1	us-gaap	Goodwill Goodwill	218484000	usd
CY2023	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-4768000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	213716000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	109093000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	16420000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	92673000	usd
CY2022Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	111796000	usd
CY2022Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	4587000	usd
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	107209000	usd
CY2022	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	usd
CY2023	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	11646000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4617000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	12133000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	12133000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	12133000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	12133000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	10995000	usd
CY2023Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	11509000	usd
CY2022Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	9712000	usd
CY2023Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	57221000	usd
CY2022Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	26167000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	68730000	usd
CY2022Q1	us-gaap	Inventory Net InventoryNet	35879000	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	48464000	usd
CY2022Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	16951000	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	22556000	usd
CY2022Q1	us-gaap	Other Assets Current OtherAssetsCurrent	19652000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	71020000	usd
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	36603000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	83600000	usd
CY2022Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	69630000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	43554000	usd
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	35037000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	40046000	usd
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	34593000	usd
CY2023	us-gaap	Depreciation Depreciation	13404000	usd
CY2022	us-gaap	Depreciation Depreciation	11840000	usd
CY2021	us-gaap	Depreciation Depreciation	10083000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	46105000	usd
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	31865000	usd
CY2023Q1	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent	14551000	usd
CY2022Q1	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent	9409000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	21495000	usd
CY2022Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	16131000	usd
CY2023Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	14232000	usd
CY2022Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	8955000	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	37100000	usd
CY2022Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	17968000	usd
CY2023Q1	chpt	Accrued Liabilities And Other Liabilities Current AccruedLiabilitiesAndOtherLiabilitiesCurrent	133483000	usd
CY2022Q1	chpt	Accrued Liabilities And Other Liabilities Current AccruedLiabilitiesAndOtherLiabilitiesCurrent	84328000	usd
CY2021Q1	chpt	Derivative Instrument Contingent Consideration Liability Shares DerivativeInstrumentContingentConsiderationLiabilityShares	18000000	shares
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	22242000	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	25535000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3753000	usd
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3876000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	21841000	usd
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	25370000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	25594000	usd
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	29246000	usd
CY2023	us-gaap	Lease Cost LeaseCost	6600000	usd
CY2022	us-gaap	Lease Cost LeaseCost	6100000	usd
CY2021	us-gaap	Lease Cost LeaseCost	5100000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	6657000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	6186000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	4983000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	4682000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	4087000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	6233000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	32828000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	7234000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	25594000	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y8M12D
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y6M
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.073
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.073
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	6927000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	5164000	usd
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	4226000	usd
CY2023	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	8429000	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	965000	usd
CY2023	us-gaap	Interest Expense Debt InterestExpenseDebt	9394000	usd
CY2023Q1	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	30400000	usd
CY2022Q1	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	400000	usd
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	348330481	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	348330481	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	334760615	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	334760615	shares
CY2023Q1	chpt	Common Stock Number Of Votes CommonStockNumberOfVotes	1	vote
CY2022Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	35549024	shares
CY2023	chpt	Warrants Exercised WarrantsExercised	1049588	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	34499436	shares
CY2021Q1	chpt	Derivative Instrument Contingent Consideration Liability Earnout Period DerivativeInstrumentContingentConsiderationLiabilityEarnoutPeriod	P5Y
CY2023	chpt	Number Of Consecutive Days Determining Earnout Triggering Event NumberOfConsecutiveDaysDeterminingEarnoutTriggeringEvent	P20D
CY2021Q1	chpt	Derivative Instrument Contingent Consideration Liability Shares Issued Net Of Shares Withheld For Taxes DerivativeInstrumentContingentConsiderationLiabilitySharesIssuedNetOfSharesWithheldForTaxes	17539657	shares
CY2021Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	743700000	usd
CY2021Q1	chpt	Reverse Recapitalization Stock Surrendered And Retired During Period Shares ReverseRecapitalizationStockSurrenderedAndRetiredDuringPeriodShares	9000000	shares
CY2023	us-gaap	Derivative Gain On Derivative DerivativeGainOnDerivative	84400000	usd
CY2021Q1	chpt	Reverse Recapitalization Stock Surrendered And Retired During Period Shares ReverseRecapitalizationStockSurrenderedAndRetiredDuringPeriodShares	9000000	shares
CY2021Q2	chpt	Reverse Recapitalization Stock Surrendered And Retired During Period Shares ReverseRecapitalizationStockSurrenderedAndRetiredDuringPeriodShares	9000000	shares
CY2021Q3	chpt	Derivative Instrument Contingent Consideration Liability Shares Issued Net Of Shares Withheld For Taxes DerivativeInstrumentContingentConsiderationLiabilitySharesIssuedNetOfSharesWithheldForTaxes	8773596	shares
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	93350000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	67331000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4947000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	191600000	usd
CY2023	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y9M18D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	22200869	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.68
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y7M6D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	292362000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	4201592	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.60
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	398753	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.76
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	17600524	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.70
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y7M6D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	201352000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	17578098	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	0.70
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P5Y7M6D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	201097000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	14356582	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.69
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y2M12D
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	164436000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.721
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.740
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.028
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.033
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-342999000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-131916000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-197908000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-4276000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-3255000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	1082000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-347275000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-135171000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-196826000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	44000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	17000	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	47000	usd
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	1345000	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	359000	usd
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	151000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1389000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	376000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	198000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	1000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-1242000	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-423000	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-3557000	usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-1641000	usd
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3556000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3306000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2167000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2930000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	198000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0
CY2023	chpt	Effective Income Tax Rate Reconciliation Warrant And Earnout Revaluation Percent EffectiveIncomeTaxRateReconciliationWarrantAndEarnoutRevaluationPercent	0
CY2022	chpt	Effective Income Tax Rate Reconciliation Warrant And Earnout Revaluation Percent EffectiveIncomeTaxRateReconciliationWarrantAndEarnoutRevaluationPercent	0.209
CY2021	chpt	Effective Income Tax Rate Reconciliation Warrant And Earnout Revaluation Percent EffectiveIncomeTaxRateReconciliationWarrantAndEarnoutRevaluationPercent	-0.078
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.080
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.002
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Amortization EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization	0
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Amortization EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization	0.013
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Amortization EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization	0
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.189
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.455
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.136
CY2023	chpt	Effective Income Tax Rate Reconciliation Transaction Cost Percent EffectiveIncomeTaxRateReconciliationTransactionCostPercent	0
CY2022	chpt	Effective Income Tax Rate Reconciliation Transaction Cost Percent EffectiveIncomeTaxRateReconciliationTransactionCostPercent	-0.012
CY2021	chpt	Effective Income Tax Rate Reconciliation Transaction Cost Percent EffectiveIncomeTaxRateReconciliationTransactionCostPercent	0
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.008
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.028
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.011
CY2023	chpt	Effective Income Tax Rate Reconciliation Section162m Executive Compensation Limitation Percent EffectiveIncomeTaxRateReconciliationSection162mExecutiveCompensationLimitationPercent	-0.012
CY2022	chpt	Effective Income Tax Rate Reconciliation Section162m Executive Compensation Limitation Percent EffectiveIncomeTaxRateReconciliationSection162mExecutiveCompensationLimitationPercent	-0.053
CY2021	chpt	Effective Income Tax Rate Reconciliation Section162m Executive Compensation Limitation Percent EffectiveIncomeTaxRateReconciliationSection162mExecutiveCompensationLimitationPercent	0
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.011
CY2022	chpt	Effective Income Tax Rate Reconciliation Permanent Differences Percent EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent	0.002
CY2021	chpt	Effective Income Tax Rate Reconciliation Permanent Differences Percent EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent	-0.006
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.006
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.022
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.001
CY2023Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	216642000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	199299000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	34406000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	25725000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	18124000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	10691000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	16742000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	10882000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	11706000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	2445000	usd
CY2023Q1	chpt	Deferred Tax Assets Operating Lease Liability DeferredTaxAssetsOperatingLeaseLiability	6589000	usd
CY2022Q1	chpt	Deferred Tax Assets Operating Lease Liability DeferredTaxAssetsOperatingLeaseLiability	7490000	usd
CY2023Q1	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	39761000	usd
CY2022Q1	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	0	usd
CY2023Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	343970000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	256532000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	328786000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	240584000	usd
CY2023Q1	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	390000	usd
CY2022Q1	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	177000	usd
CY2023Q1	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	5723000	usd
CY2022Q1	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	6550000	usd
CY2023Q1	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	22058000	usd
CY2022Q1	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	26918000	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	28171000	usd
CY2022Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	33645000	usd
CY2023Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	12987000	usd
CY2022Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	17697000	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	88200000	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	89600000	usd
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	16700000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	604300000	usd
CY2022Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	19238000	usd
CY2021Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	9402000	usd
CY2020Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	10153000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	109000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	2039000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	3620000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	6415000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	7797000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	2869000	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	25762000	usd
CY2022Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	19238000	usd
CY2021Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	9402000	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	25800000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	468094000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	241006000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	146490000	usd
CY2023Q1	us-gaap	Noncurrent Assets NoncurrentAssets	154961000	usd
CY2022Q1	us-gaap	Noncurrent Assets NoncurrentAssets	167337000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-345108000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-132241000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-197024000	usd
CY2023	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	0	usd
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	0	usd
CY2021	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	60377000	usd
CY2023	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	0	usd
CY2022	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	4292000	usd
CY2021	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	16799000	usd
CY2023	chpt	Deemed Dividends Attributable To Vested Option Holders DeemedDividendsAttributableToVestedOptionHolders	0	usd
CY2022	chpt	Deemed Dividends Attributable To Vested Option Holders DeemedDividendsAttributableToVestedOptionHolders	51855000	usd
CY2021	chpt	Deemed Dividends Attributable To Vested Option Holders DeemedDividendsAttributableToVestedOptionHolders	0	usd
CY2023	chpt	Deemed Dividends Attributable To Common Stock Warrant Holders DeemedDividendsAttributableToCommonStockWarrantHolders	0	usd
CY2022	chpt	Deemed Dividends Attributable To Common Stock Warrant Holders DeemedDividendsAttributableToCommonStockWarrantHolders	110635000	usd
CY2021	chpt	Deemed Dividends Attributable To Common Stock Warrant Holders DeemedDividendsAttributableToCommonStockWarrantHolders	0	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-345108000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-299023000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-274200000	usd
CY2023	chpt	Dilutive Securities Effect On Basic Earnings Per Share Dilutive Gain On Earnout Shares Issued DilutiveSecuritiesEffectOnBasicEarningsPerShareDilutiveGainOnEarnoutSharesIssued	0	usd
CY2022	chpt	Dilutive Securities Effect On Basic Earnings Per Share Dilutive Gain On Earnout Shares Issued DilutiveSecuritiesEffectOnBasicEarningsPerShareDilutiveGainOnEarnoutSharesIssued	84420000	usd
CY2021	chpt	Dilutive Securities Effect On Basic Earnings Per Share Dilutive Gain On Earnout Shares Issued DilutiveSecuritiesEffectOnBasicEarningsPerShareDilutiveGainOnEarnoutSharesIssued	0	usd
CY2023	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	0	usd
CY2022	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	-68223000	usd
CY2021	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	0	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-345108000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-451666000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-274200000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	338576326	shares
CY2022	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	297642999	shares
CY2021	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	15116763	shares
CY2023	chpt	Weighted Average Number Of Shares Restricted Stock Unvested And Subject To Repurchase WeightedAverageNumberOfSharesRestrictedStockUnvestedAndSubjectToRepurchase	87659	shares
CY2022	chpt	Weighted Average Number Of Shares Restricted Stock Unvested And Subject To Repurchase WeightedAverageNumberOfSharesRestrictedStockUnvestedAndSubjectToRepurchase	221030	shares
CY2021	chpt	Weighted Average Number Of Shares Restricted Stock Unvested And Subject To Repurchase WeightedAverageNumberOfSharesRestrictedStockUnvestedAndSubjectToRepurchase	0	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	338488667	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	297421969	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15116763	shares
CY2023	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	0	shares
CY2022	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	3701427	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	0	shares
CY2023	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2022	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	1366870	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	338488667	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	302490266	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15116763	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.02
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.01
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-18.14
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.02
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.49
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-18.14
CY2022Q1	chpt	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	0.9966
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	79395156	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	62809839	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	262337147	shares
CY2023	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	0	usd

Files In Submission

Name	View Source	Status
0001777393-23-000008-index-headers.html	Edgar Link	pending
0001777393-23-000008-index.html	Edgar Link	pending
0001777393-23-000008.txt	Edgar Link	pending
0001777393-23-000008-xbrl.zip	Edgar Link	pending
chargepoint10k2023ex1027.htm	Edgar Link	pending
chargepoint10k2023ex1028.htm	Edgar Link	pending
chargepoint10k2023ex1028001.jpg	Edgar Link	pending
chargepoint10k2023ex1028002.jpg	Edgar Link	pending
chargepoint10k2023ex1028003.jpg	Edgar Link	pending
chargepoint10k2023ex1028004.jpg	Edgar Link	pending
chargepoint10k2023ex211.htm	Edgar Link	pending
chargepoint10k2023ex231.htm	Edgar Link	pending
chargepoint10k2023ex311.htm	Edgar Link	pending
chargepoint10k2023ex312.htm	Edgar Link	pending
chargepoint10k2023ex321.htm	Edgar Link	pending
chargepoint10k2023ex322.htm	Edgar Link	pending
chargepoint10k2023exhibit43.htm	Edgar Link	pending
chpt-20230131.htm	Edgar Link	pending
chpt-20230131.xsd	Edgar Link	pending
chpt-20230131_g1.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
chpt-20230131_def.xml	Edgar Link	unprocessable
chpt-20230131_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
chpt-20230131_htm.xml	Edgar Link	completed
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
chpt-20230131_cal.xml	Edgar Link	unprocessable
chpt-20230131_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CHPT
ChargePoint Holdings, Inc. Stock $chpt

2023 Q1 Form 10-K Financial Statement

#000177739323000008 Filed on April 03, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CHPT ChargePoint Holdings, Inc. Stock $chpt

2023 Q1 Form 10-K Financial Statement

#000177739323000008 Filed on April 03, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CHPT
ChargePoint Holdings, Inc. Stock $chpt